尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Dorval Allison, 董事. Officer active across 2 companies, notably Puma Biotechnology, INC.. In total, 10 disclosures have been recorded. Split: 0 buy · 3 sells. Total volume traded: €67k. Activity tracked since 14 June 2022. The latest transaction was disclosed on 18 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Allison Dorval is a Board Member at Puma Biotechnology, Inc. She plays a key role in the governance of the company, bringing her expertise and experience in the biopharmaceutical sector. As a board member, she is involved in overseeing Puma Biotechnology's activities and making strategic decisions that influence its future. Her commitment to compliance and performance is essential for the company.